TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including the Independent Payment Advisory Board; "HR 4223 "Strenghthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "Safe Doses Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR 2405 and S 1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR 3627 and S 1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of pandemic and biodefence funding in FY2012 and related international intellectual property issues; and education and awareness of dengue.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Medicare/Medicaid MMM
Issues related to changing reimbursement under the Medicare Part B program.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Economics/Economic Development ECN
General issues related to foreign direct investment in the United States, including all provisions of S. 3274 and H.R. 5910 "Global Investment in American Jobs Act of 2012".
Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc., as disclosed on its LD-1.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Medical/Disease Research/Clinical Labs MED
S 810 and HR 1513 "Great Ape Protection and Cost Savings Act of 2011" - all provisions.
Foreign entity interest: Sanofi US Services Inc. is owened by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.